{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:08:04Z","timestamp":1764331684471},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T00:00:00Z","timestamp":1181174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2007,8,9]]},"DOI":"10.1007\/s11864-007-0021-5","type":"journal-article","created":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T20:40:46Z","timestamp":1181162446000},"page":"61-73","source":"Crossref","is-referenced-by-count":22,"title":["New Insights into Breast Cancer Genetics and Impact on Patient Management"],"prefix":"10.1007","volume":"8","author":[{"given":"Diana S.","family":"Rosman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Kaklamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Pasche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,7]]},"reference":[{"key":"21_CR1","unstructured":"NCCN Clinical Practice Guidelines in Oncology. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/genetics_screening.pdf . 2006. 2006. Ref Type: Electronic Citation"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2005.03.3126","volume":"24","author":"N Andrieu","year":"2006","unstructured":"Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R,Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van\u2019t VL, Van Leeuwen FE, Goldgar DE Effect of chest X-rays on the risk of breast cancer among BRCA1\/2 mutation carriers in the international BRCA1\/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators\u2019 Group. J Clin Oncol 2006a, 24:3361\u20133366","journal-title":"J Clin Oncol"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnci\/djj132","volume":"98","author":"N Andrieu","year":"2006","unstructured":"Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G, Eccles D, Douglas F, Nogues C, Gauthier-Villars M, Chompret A, Van Leeuwen FE, Kluijt I, Benitez J, Arver B, Olah E, Chang-Claude J Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1\/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 2006b, 98:535\u2013544","journal-title":"J Natl Cancer Inst"},{"key":"21_CR4","doi-asserted-by":"crossref","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003, 72(5):1117\u20131130.","DOI":"10.1086\/375033"},{"key":"21_CR5","first-page":"211","volume":"11","author":"SW Baxter","year":"2002","unstructured":"Baxter SW, Choong DY, Eccles DM, Campbell IG Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:211\u2013214","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"21_CR6","first-page":"1298","volume":"4","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994,4:1298\u20131304","journal-title":"Cancer Res"},{"key":"21_CR7","doi-asserted-by":"crossref","unstructured":"Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst (2006) 98:1382\u20131396","DOI":"10.1093\/jnci\/djj374"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00304-X","volume":"105","author":"SB Cantor","year":"2001","unstructured":"Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 2001, 105:149\u2013160","journal-title":"Cell"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<43::AID-IJC9>3.0.CO;2-0","volume":"82","author":"T Chen","year":"1999","unstructured":"Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A, Reiss M Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 1999, 82:43\u201351","journal-title":"Int J Cancer"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/nar\/gkl010","volume":"34","author":"CX Deng","year":"2006","unstructured":"Deng CX BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006, 34:1416\u20131426","journal-title":"Nucleic Acids Res"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van\u2019t VL, Lynch HT, Olopade OI, Weber BL, Rebbeck TR Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 2006, 7:223\u2013229","journal-title":"Lancet Oncol"},{"key":"21_CR12","first-page":"2610","volume":"63","author":"AM Dunning","year":"2003","unstructured":"Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63:2610\u20132615","journal-title":"Cancer Res"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","volume":"23","author":"A Eisen","year":"2005","unstructured":"Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, Isaacs C, Kim-Sing C, Ainsworth P, Sun P, Narod SA Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol (2005, 23:7491\u20137496","journal-title":"J Clin Oncol"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/sj.onc.1209871","volume":"25","author":"B Evers","year":"2006","unstructured":"Evers B, Jonkers J Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 2006, 25:5885\u20135897","journal-title":"Oncogene"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","volume":"296","author":"A Finch","year":"2006","unstructured":"Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 2006, 296:185\u2013192","journal-title":"JAMA"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005, 97:1652\u20131662","journal-title":"J Natl Cancer Inst"},{"key":"21_CR17","first-page":"E9","volume":"2","author":"B Friedenson","year":"2000","unstructured":"Friedenson B Is mammography indicated for women with defective BRCA genes? Implications of recent scientific advances for the diagnosis, treatment, and prevention of hereditary breast cancer. MedGenMed 2000, 2:E9","journal-title":"MedGenMed"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s001980050163","volume":"9","author":"DJ Grainger","year":"1999","unstructured":"Grainger DJ, Percival J, Chiano M, Spector TD The role of serum TGF-beta isoforms as potential markers of osteoporosis. Osteoporos Int 1999, 9:398\u2013404","journal-title":"Osteoporos Int"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","volume":"20","author":"VR Grann","year":"2002","unstructured":"Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis. J Clin Oncol 2002, 20:2520\u20132529","journal-title":"J Clin Oncol"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.21536","volume":"118","author":"J Gronwald","year":"2006","unstructured":"Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 2006, 118:2281\u20132284","journal-title":"Int J Cancer"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20370","volume":"%20;112","author":"Q Jin","year":"2004","unstructured":"Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Forsti A Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers. Int J Cancer 2004, %20;112:94\u201399","journal-title":"Int J Cancer"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-04-2961","volume":"65","author":"VG Kaklamani","year":"2005","unstructured":"Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Res 2005 65:3454\u20133461","journal-title":"Cancer Res"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002, 346:1609\u20131615","journal-title":"N Engl J Med"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36\u201347","journal-title":"Epidemiol Rev"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001, 286:2251\u20132256","journal-title":"JAMA"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2. Science 2003, 302:643\u2013646","journal-title":"Science"},{"key":"21_CR27","doi-asserted-by":"crossref","unstructured":"Kote-Jarai Z, Powles TJ, Mitchell G, Tidy A, Ashley S, Easton D, Assersohn L, Sodha N, Salter J, Gusterson B, Dowsett M, Eeles R: BRCA1\/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial. Cancer Lett 2006.","DOI":"10.1016\/j.canlet.2006.05.003"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1200\/JCO.2005.02.9199","volume":"23","author":"JL Kramer","year":"2005","unstructured":"Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 2005, 23:8629\u20138635","journal-title":"J Clin Oncol"},{"key":"21_CR58","doi-asserted-by":"crossref","unstructured":"Kriege M, Brekelmans CT, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA, Besnard AP, Tilanus-Linthorst MM, Seynaeve C, Bartels CC, Kaas R, Meijer S, Oosterwijk JC, Hoogerbrugge N, Tollenaar RA, Rutgers EJ, de Koning HJ, Klijn JG: Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat 2006.","DOI":"10.1007\/s10549-006-9230-z"},{"key":"21_CR29","doi-asserted-by":"crossref","unstructured":"Kriege et al: Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. N Engl J Med 2004, 351:427\u2013437, July 29, 2004","DOI":"10.1056\/NEJMoa031759"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(03)00468-3","volume":"201","author":"P Krippl","year":"2003","unstructured":"Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Bahadori B, Samonigg H The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett 2003, 201:181\u2013184","journal-title":"Cancer Lett"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejca.2005.11.032","volume":"42","author":"F Lalloo","year":"2006","unstructured":"Lalloo F, Varley J, Moran A, Ellis D, O\u2019dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 2006, 42:1143\u20131150","journal-title":"Eur J Cancer"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"15406","DOI":"10.1073\/pnas.95.26.15406","volume":"95","author":"DM Li","year":"1998","unstructured":"Li DM, Sun H PTEN\/MMAC1\/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 1998, 95:15406\u201315411","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21_CR33","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr., Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW A cancer family syndrome in twenty-four kindreds. Cancer Res 1988, 48:5358\u20135362","journal-title":"Cancer Res"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78\u201385","journal-title":"N Engl J Med"},{"key":"21_CR35","unstructured":"Meijers-Heijboer H, van den OA, Klijn J, Wasielewski M, de SA, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van DC, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002, 31:55\u201359"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van GB, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001, 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.J Clin Oncol 2004, 22: 2328\u20132335","journal-title":"J Clin Oncol"},{"key":"21_CR38","first-page":"1876","volume":"356","author":"SA Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los RP, Weber B, Lynch H Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000, 356:1876\u20131881","journal-title":"Hereditary Breast Cancer Clinical Study Group. Lancet"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1470-2045(06)70624-6","volume":"7","author":"SA Narod","year":"2006","unstructured":"Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Rosen B, Kim-Sing C, Isaacs C, Domchek S, Sun P Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 2006, 7:402\u2013406","journal-title":"Lancet Oncol"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.2004.99.271","volume":"22","author":"B Pasche","year":"2004","unstructured":"Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004, 22:756\u2013758","journal-title":"J Clin Oncol"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jama.294.13.1634","volume":"294","author":"B Pasche","year":"2005","unstructured":"Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D, Kaklamani V, Baddi L, Siddiqui FS, Frankel W, Prior TW, Schuller DE, Agrawal A, Lang J, Dolan ME, Vokes EE, Lane WS, Huang CC, Caldes T, Di CA, Hampel H, Nilsson I, von HG, Fodde R, Murty VV, de la CA, Weghorst CM Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 2005, 294:1634\u20131646","journal-title":"JAMA"},{"key":"21_CR42","first-page":"5678","volume":"59","author":"B Pasche","year":"1999","unstructured":"Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massague J, Offit K TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999, 59:5678\u20135682","journal-title":"Cancer Res"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","volume":"23","author":"TR Rebbeck","year":"2005","unstructured":"Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van V, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, Eisen A, Domchek S, Armstrong K, Weber BL Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2005, 23:7804\u20137810","journal-title":"J Clin Oncol"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t VL, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002, 346:1616\u20131622","journal-title":"N Engl J Med"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA 2002, 288:321\u2013333","journal-title":"JAMA"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006, 38: 1239\u20131241","journal-title":"Nat Genet"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1055-9965.EPI-05-0078","volume":"14","author":"A Shin","year":"2005","unstructured":"Shin A, Shu XO, Cai Q, Gao YT, Zheng W Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 2005, 14: 1567\u20131570","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3322\/canjclin.56.3.168","volume":"56","author":"C Smigal","year":"2006","unstructured":"Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006, 56:168\u2013183","journal-title":"CA Cancer J Clin"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.11384","volume":"108","author":"K Syrjakoski","year":"2004","unstructured":"Syrjakoski K, Kuukasjarvi T, Auvinen A, Kallioniemi OP CHEK2 1100delC is not a risk factor for male breast cancer population. Int J Cancer 2004, 108:475\u2013476","journal-title":"Int J Cancer"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1086\/301607","volume":"61","author":"HC Tsou","year":"1997","unstructured":"Tsou HC, Teng DH, Ping XL, Brancolini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV, Peacocke M The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Hum Genet 1997, 61:1036\u20131043","journal-title":"Am J Hum Genet"},{"key":"21_CR51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(01)00259-3","volume":"12","author":"LM Wakefield","year":"2002","unstructured":"Wakefield LM, Roberts AB TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002, 12:22\u201329","journal-title":"Curr Opin Genet Dev"},{"key":"21_CR52","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006, 295:1379\u20131388","journal-title":"JAMA"},{"key":"21_CR53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.annepidem.2005.02.015","volume":"16","author":"MH Wu","year":"2006","unstructured":"Wu MH, Chou YC, Yu JC, Yu CP, Wu CC, Chu CM, Yang T, Lai CH, Hsieh CY, You SL, Chen CJ, Sun CA Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 2006, 16:223\u2013229","journal-title":"Ann Epidemiol"},{"key":"21_CR54","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/01.CIR.101.24.2783","volume":"101","author":"M Yokota","year":"2000","unstructured":"Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y Association of a T29\u2013>C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000, 101:2783\u20132787","journal-title":"Circulation"},{"key":"21_CR55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida K, Miki Y Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 2004, 95:866\u2013871","journal-title":"Cancer Sci"},{"key":"21_CR56","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1200\/JCO.2005.02.9108","volume":"23","author":"HT Zhang","year":"2005","unstructured":"Zhang HT, Zhao J, Zheng SY, Chen XF Is TGFBR1*6A Really Associated With Increased Risk of Cancer? J Clin Oncol 2005, 23:7743\u20137744","journal-title":"J Clin Oncol"},{"key":"21_CR57","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.285.22.2859","volume":"285","author":"E Ziv","year":"2001","unstructured":"Ziv E, Cauley J, Morin PA, Saiz R, Browner WS Association between the T29\u2013>C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. JAMA 2001, 285:2859\u20132863","journal-title":"JAMA"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-007-0021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-007-0021-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-007-0021-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:01:45Z","timestamp":1683874905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-007-0021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,7]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,8,9]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11864-007-0021-5","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,7]]}}}